Genomic Diagnostics

Site

GD Vic – Healius Pathology Pty Ltd

Accreditation No.

19619

Site No.

22717

Date of Accreditation

17 Dec 2014

Address

460 Lower Heidelberg Road
Heidelberg, VIC 3084
Australia

sdspathology.com.au

Contact

Ms Shelly Sanders P: +61 (03) 99182030

Availability

Services available to external clients

Supervision

GX (General)

Scope of Accreditation

GD Vic – Healius Pathology Pty Ltd

ISO 15189 (2012)

Human Pathology

Medicare expiry date

01 Mar 2024

Last Activity Date

02 Apr 2021

Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blood Apolipoprotein E genotyping; Thiopurine methyltransferase (TPMT); α1-Antitrypsin
Coeliac disease
Cystic fibrosis; Fragile X
Fragile X; Gilberts disease
Factor V Leiden; HLA-B27; Haemochromatosis; Methylenetetrahydrofolate reductase (MTHFR); Prothrombin variant; Thrombophilia
Molecular genetics - Bioinformatic analysis DNA sequences Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation
Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes Blood Qualitative calculation of p190 positive BCR::ABL1 transcripts; Quantitative calculation of p190 positive BCR::ABL1
Quantitative calculation of p210 positive BCR::ABL1 transcripts
Myeloproliferative disorders
Formalin-fixed paraffin-embedded (FFPE) tissues KIT mutation analysis; Solid tumoursERBB2 mutation analysis
BRAF mutation analysis; EGFR mutation analysis; KRAS mutation analysis; NRAS mutation analysis; Solid tumours
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes Formalin-fixed paraffin-embedded (FFPE) tissues Solid tumours
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Blood Breast cancer; Hereditary colorectal cancer; Inherited disorders; Spinal muscular atrophyOvarian cancer
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes Blood Breast cancer; Cystic fibrosis; Hereditary colorectal cancer; Inherited disordersOvarian cancer
Hereditary breast and ovarian syndrome
Breast cancer; Cystic fibrosis; Hereditary colorectal cancer; Inherited disordersOvarian cancer
Breast cancer; Hereditary colorectal cancer; Inherited disorders
Molecular genetics - Non-invasive prenatal (genetic) screening Maternal blood Aneuploidy for chromosomes X and Y; Rare autosome aneuploidy and segmental genomic imbalances; Trisomy 13, trisomy 18, trisomy 21
Molecular genetics - Predictive genetic testing - Targeted genes Blood Breast cancer; Hereditary colorectal cancer; Inherited disorders
Breast cancer; Hereditary colorectal cancer; Inherited disorders

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.